BUZZ-Haemonetics hits two-year low after cutting sales growth forecast

Medical equipment maker Haemonetics' HAE.N shares fall 8.3% to $65.3 to touch an over 2-1/2 year low

Co cuts its sales growth forecast for fiscal 2025 to 3%-5% from 5%-8%

Co reports Q3 revenue of $349 million, missing analyst estimates of $353 million - data compiled by LSEG

Co posts adj Q3 profit of $1.19 per share, beating analyst estimates of $1.17 per share - LSEG

Shares are down ~17% in the past 12 months